Dividends & Buybacks ·
Glucotrack, Inc. filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of…
GCTKGlucotrack, Inc.
Glucotrack, Inc. filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State, effecting a one-for-fifteen (1-for-15) reverse stock split effective August 28, 2026. The transaction was approved by stockholders at the annual meeting on August 18, 2026. Consequently, outstanding common shares decreased from approximately 11,972,157 to roughly 798,144, while authorized shares remained unchanged at 250,000,000. Stock options and warrants were adjusted proportionally with corresponding exercise price increases. The company will begin trading on a split-adjusted basis on August 31, 2026, under the same ticker symbol GCTK. Glucotrack operates in the healthcare technology sector, developing digital health solutions for diabetes management.